Country - United Kingdom
Summary - Nhs National Framework For Medical Retinal Vascular Treatments - 1 December 2025
Deadline - Mar 21, 2026
MT reference number - 105467982
Product classification - Pharmaceutical products
Address - United Kingdom
Contact details - 565656565
Tender notice no. - 76454545
MT Ref Id - 105467982
Document Type - Tender Notices
Description - Description: Provision of Medical Retinal Vascular Anti Veg-F and Intravitreal Corticosteroid medicines used in medical retinal vascular services for the NHS in England. To include but not limited to aflibercept, bevacizumab, brolucizumab, intravitre al dexamethasone, intravitreal fluocinolone, faricimab and ranibizumab used in the treatment of; • neovascular (wet) age-related macular degeneration (AMD) • visual impairment due to macular oedema secondary to retinal vein occlusion (branch RVO or central RVO) • proliferative diabetic retinopathy (PDR) • visual impairment due to diabetic macular oedema (DME) • visual impairment due to diabetic macular oedema (DME) who are pseudophakic
Mt Ref Id - 105467982
Deadline - Mar 21, 2026
Similar Tenders :
Healthcare and Medicine